XML 55 R44.htm IDEA: XBRL DOCUMENT v3.21.2
Stock Incentive Plans - Summary of Option Activity under Plans (Details)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]    
Number of Options, Outstanding at Beginning Balance | shares 5,840,824  
Number of Options, Granted | shares 1,902,700  
Number of Options, Exercised | shares (59,348)  
Number of Options, Cancelled/Forfeited | shares (158,374)  
Number of Options, Outstanding at Ending Balance | shares 7,525,802 5,840,824
Number of Options, Vested and Expected to vest at March 31, 2021 | shares 7,525,802  
Number of Options, Exercisable at March 31, 2021 | shares 3,716,324  
Weighted-Average Exercise Price per Share, Outstanding at Beginning Balance | $ / shares $ 15.18  
Weighted-Average Exercise Price per Share, Granted | $ / shares 12.84  
Weighted-Average Exercise Price per Share, Exercised | $ / shares 2.30  
Weighted-Average Exercise Price per Share, Cancelled/Forfeited | $ / shares 18.62  
Weighted-Average Exercise Price per Share, Outstanding at Ending Balance | $ / shares 14.62 $ 15.18
Weighted-Average Exercise Price per Share, Vested and Expected to vest at March 31, 2021 | $ / shares 14.62  
Weighted-Average Exercise Price Per Share, Exercisable at March 31, 2021 | $ / shares $ 13.21  
Weighted Average Remaining Contractual Term, Outstanding 8 years 7 years 9 months 18 days
Weighted Average Remaining Contractual Term, Vested and Expected to vest at March 31, 2021 8 years  
Weighted Average Remaining Contractual Term, Exercisable at March 31, 2021 7 years  
Aggregate Intrinsic Value, Outstanding Ending Balance | $ $ 5,300 $ 12,278
Aggregate Intrinsic Value, Vested and Expected to vest at March 31, 2021 | $ 5,300  
Aggregate Intrinsic Value, Exercisable at March 31, 2021 | $ $ 5,131